Endocyte Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 11 of 11 Posts
Novartis Acquires Endocyte For $24 Per Share Or $2.1B In Cash
Article By: The Fly Thursday, October 18, 2018 7:53 AM EST
Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share.
In this article: NVS, ECYT
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA Friday, May 18, 2018 8:41 PM EST
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
Endocyte Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Friday, March 2, 2018 9:35 PM EST
Endocyte, Inc. announced today the closing of an underwritten registered public offering of 20,535,714 shares of its common stock.
In this article: ECYT
Read
Endocyte Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Wednesday, February 28, 2018 12:07 PM EST
Endocyte, Inc. today the pricing of an underwritten registered public offering of 17,857,143 shares of its common stock at a price to the public of $4.20 per share.
In this article: ECYT
Read
Best Stock Charts - Wednesday, April 5
Article By: Robert Desmond Wednesday, April 5, 2017 11:29 PM EST
Overall our opinion on the market is that they are weak and getting weaker. We are focusing in on shorting the markets to make big profits to short side.
In this article: ECYT, QQQ, BBBY, CBOE, FIZZ, SCHN, COOL, RCON, GDX, GLD, IWM, NUGT, TZA, UUP, ALDX, AAOI
Read
Best Stock Charts - Sunday, April 2
Video By: Robert Desmond Sunday, April 2, 2017 10:32 PM EST
Let's discuss overbought stocks and how we plan on using the Relative Strength Index to first buy the shares. And then let's also look to sell the same shares short.
In this video: AMD, ITT, DEPO, ECYT, SILC, CBOE, FIZZ, PNRA, RNWK, SCHN, COOL
Watch
5 Cheap Breakout Stocks For Superb Returns
Article By: Swarup Gupta Thursday, March 16, 2017 1:07 PM EST
One of the most popular methods utilized by active investors is to select breakout stocks. The technique identifies those stocks whose prices are fluctuating within a specific band.
In this article: ALQA, ECYT, NMM, ITCI, RIGL
Read
16 Stocks That Are Way Cheaper Than They Look
Article By: Steve Alexander Friday, August 21, 2015 12:50 PM EST
Which stocks are way cheaper - or more expensive - than they look, today?
In this article: AP, BPI, CBK, CGA, FF, NSU, AOSL, AWRE, ECYT, GENC, GSIT, KLIC, CPIX, WILC, VC, TWMC
Read
Mallinckrodt Tops Q2 Earnings & Revenues On Acquisitions
Article By: Zacks Investment Research Tuesday, May 5, 2015 1:49 PM EST
Stocks rise 5% on positive news.
In this article: MNK, ACT, ECYT, SHPG
Read
EC Bioniche: A Home Run Buying Opportunity In Biotech
Article By: SecretCaps Thursday, September 18, 2014 9:38 AM EST
There is a critical medical need for Bioniche's technology in a $1 billion market virtually free of real competition, which opens the door for massive revenue growth, while the sound financials limits downside risk. Overall, today's $0.20 share price appears to me as an excellent entry point...
In this article: BNHLF, ECYT, ONTY, GALE
Read
E EC Interview With Endocyte Management
Article By: Trevor Lowenthal Thursday, May 29, 2014 12:48 PM EST
Interview excerpts with Mike Sherman, CFO of Endocyte.
In this article: ECYT
Read
1 to 11 of 11 Posts